Loading…
← CockpitCompetitor Analysis › 002734.SZ Limin Group Co., Ltd. Class AOpen in the cockpit ↗

Limin Group Co., Ltd. Class A002734.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Agricultural

Chinese pesticide manufacturer producing insecticides and other crop-protection chemicals.

Momentum laggard 4
Mkt cap
$778M
US dollars, full cap
Free float
62%
of shares outstanding
$/day
$42.9M
20-day average traded
Fwd P/E
9.2×
forward earnings
ROIC−WACC
+2.2 pp
WACC 7.5%
Hurdle
-2 pp
Req g minus delivered
Next earnings
161 days
16 Apr 2027
Close · CNYCN¥11.34
1D-3.4%
1W+1.1%
1M-36.7%
3M-16.2%
6M-37.1%
YTD-28.9%
1Y-37.5%
ATR %7.2%
52w lowhigh50.2% off high

What Limin does

Chinese pesticide manufacturer producing insecticides and other crop-protection chemicals.

Products and services

  • Insecticides
  • Other crop-protection chemicals

Customers

  • Agrochemical distributors
  • Export markets

Where it sits in the supply chain

  • Materials
  • Agricultural chemicals
  • Pesticides

What could go right

  • Crop-protection demand

What could go wrong

  • Pesticide price competition

Moat: none. Commodity pesticide producer in a fragmented, price-competitive domestic market.

Headquarters: Hebei, China · Employees: 4,593

Named competitors

Limin at a glance

Size Limin (002734.SZ) is a China Materials company (Chemicals: Agricultural) with a market value of $778M, the 2836th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥11.34 on 6 Nov 2026.

Performance Over six months the shares fell 37.1%, against -22.5% for the median peer and -16.4% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue fell 6.5% over the last twelve months (peer median +8.9%); the operating margin is 8.4% (peer median 3.3%).

Valuation It trades at 9.2× forward earnings against a peer median of 13.5× (3rd cheapest of 9).

Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +1%, so the hurdle is -2 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.2 points above its cost of capital (7.5% WACC).

Next results Next results expected around 16 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010011 May 202611 Aug 20266 Nov 2026Peer median 78002734.SZ 63
Six months, rebased to 100: Limin against the median of its 20 peers (local-currency closes).

Limin financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.19BCN¥4.52BCN¥4.24BCN¥4.19BCN¥5.01B
Revenue growth—+7%+1%-16%—
Gross profitCN¥1.26BCN¥1.10BCN¥729MCN¥609MCN¥865M
EBITDAn/aCN¥915MCN¥509MCN¥471MCN¥530M
Net incomeCN¥306MCN¥480MCN¥81.4MCN¥62.1MCN¥219M
Free cash flowCN¥426MCN¥465MCN¥269MCN¥229M-CN¥66.3M
Capital expenditureCN¥73.9MCN¥86.9MCN¥98.0MCN¥237MCN¥735M
Total debtCN¥1.87BCN¥1.62BCN¥3.00BCN¥2.98BCN¥2.76B

Quarterly statements and history in the cockpit →

Limin competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-40%-20%0%KRISHANALXU002538603395600227002470300505FMCNUF002749000713MBAPLODCOCI000525603334002734.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Limin is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×60×LXU300505FMCNUF002749000713002556GSFC002734.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Limin is the large dot.

Capital: growth delivered against growth the price implies

-10%0%+10%+20%-10%0%10%20%LXU600227FMCNUF002749000713ODC600796000525002556GSFC002734.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Limin is the large dot.

Limin competitors and peer comparison

Head to head with its named competitors (002734.SZ vs 600486.SS vs 002215.SZ)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Limin 002734.SZ$778M-37%-6%8%9.2×-1.2%
Jiangsu Yangnong Chemical 600486.SS$3.42B-22%+3%13%16.2×0.8%
Shenzhen Noposion Crop Science 002215.SZ$1.25B-23%+12%13%9.3×-3.9%

How Limin compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Limin against its 20 peers (data as of 6 Nov 2026)
Measure002734.SZPeer medianRank in peer set
1-month return-36.7%-6.7%2nd lowest of 21
6-month return-37.1%-22.5%4th lowest of 21
Distance from 52-week high-50.2%-34.8%5th lowest of 21
Revenue growth (TTM)-6.5%+8.9%3rd lowest of 21
Operating margin8.4%3.3%8th highest of 21
Forward P/E9.2×13.5×3rd cheapest of 9
Growth the price implies (Req g, 7 yrs)-1.2%8.7%3rd least demanding of 12
Growth delivered (Del g)+0.6%+3.2%5th lowest of 12
Hurdle (Req g minus delivered)-1.8 pp+7.9 pp4th least demanding of 12
ROIC minus cost of capital+2.2 pp-2.2 pp5th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Limin 002734.SZChina$778M-37%-6%8%9.2×-1.2%+0.6%
Krishana Phoschem KRISHANA.NSIndia$781M+79%+73%11%n/an/an/a
LSB Industries LXUUnited States$763M-24%+13%11%13.7×-0.8%+11.9%
Anhui Sierte Fertilizer Industry 002538.SZChina$794M-15%+9%3%n/an/an/a
CNSIG Anhui Hongsifang Fertilizer 603395.SSChina$798M-23%+3%0%n/an/an/a
Guizhou Chitianhua 600227.SSChina$803M-22%-2%-5%n/a10.3%+2.4%
Kingenta Ecological Engineering 002470.SZChina$827M-39%+9%-5%n/an/an/a
Kunming Chuan Jin Nuo Chemical 300505.SZChina$838M-34%+14%10%9.2×n/an/a
FMC FMCUnited States$876M-58%-22%-21%6.2×-2.8%-5.7%
Nufarm NUF.AXAustralia$897M+40%-2%3%62.4×9.9%+5.2%
Sichuan Guoguang Agrochemical 002749.SZChina$668M-24%-2%18%13.3×-8.5%+12.2%
Sdic Fengle Seed 000713.SZChina$664M-15%+10%2%37.0×12.2%+3.4%
Madhya Bharat Agro Products MBAPL.NSIndia$944M+68%+48%10%n/an/an/a
Oil-Dri Corporation of America ODCUnited States$948M-9%+2%14%n/a3.8%+10.1%
Zhejiang Qianjiang Biochemical 600796.SSChina$629M-24%-2%11%n/a7.8%-2.0%
Oci OCI.ASNetherlands$967M+8%-81%-4%n/an/an/a
Nanjing Redsun 000525.SZChina$981M-10%+12%-2%n/a12.2%-5.1%
Anhui Huilong Agricultural Means of Production .Co 002556.SZChina$594M-31%0%1%19.0×8.7%-1.2%
Rashtriya Chemicals & Fertilizers RCF.NSIndia$590M-23%+18%4%n/an/an/a
Gujarat State Fertilizers & Chemicals GSFC.NSIndia$588M-22%+37%3%8.7×23.2%+3.2%
Suzhou Fengbei Biotech Stock 603334.SSChina$586M-44%+63%4%n/an/an/a

Questions

Who are Limin's main competitors?
Named competitors: Jiangsu Yangnong Chemical (600486.SS), Shenzhen Noposion Crop Science (002215.SZ). The cockpit's measured peer set (industry) also includes Krishana Phoschem (KRISHANA.NS), LSB Industries (LXU), Anhui Sierte Fertilizer Industry (002538.SZ), CNSIG Anhui Hongsifang Fertilizer (603395.SS), Guizhou Chitianhua (600227.SS), Kingenta Ecological Engineering (002470.SZ).
Is Limin expensive compared with its peers?
On forward p/e it trades at 9.2× against a peer median of 13.5×, 3rd cheapest of 9 in its peer set. For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +1%, so the hurdle is -2 pp: the price already allows for a slowdown.
How has Limin stock performed?
Over six months to 6 Nov 2026 the shares returned -37.1% against -22.5% for the median peer; over one year -37.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.